S-1

Company

Lexeo Therapeutics, Inc.

Filed

April 9, 2024

Accession Number

0001193125-24-090233

An S-1 is a registration statement filed by a company preparing for its initial public offering (IPO). It discloses the business model, financials, risk factors, and use of proceeds. Learn more about S-1 filings →